as on December 8, 2025 at 4:01 pm IST
Day's Low
Day's High
0.49%
Downside
5.92%
Upside
52 Week's Low
52 Week's High
24.77%
Downside
35.74%
Upside
as on December 8, 2025 at 4:01 pm IST
Market Cap
₹782.65 Cr
Return on Equity (ROE)
0.64
PE Ratio (TTM)
2.79
Return on capital employed (ROCE)
1.09
Industry PE ratio
42.28
Beta (LTM)
0.77
P/B Ratio
0.53
Dividend Yield
0PEG Ratio
-0.05
Quarterly Earnings Growth YOY
1910
EPS (TTM)
36.44
Sector
Pharmaceuticals
Book Value
159.86
Technical Analysis
Bearish
View Technical Analysis
as on December 8, 2025 at 4:01 pm IST
Ind-Swift Laboratories Ltd in the last 5 years
Lowest (-1795.00x)
December 8, 2022
Today (2.79x)
December 5, 2025
Industry (42.28x)
December 5, 2025
Highest (64.97x)
July 19, 2021
Today’s Price to Earnings Ratio: 2.79x
Compare market cap, revenue, PE, and other key metrics of Ind-Swift Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 782.65 | 10.86% | 0.52 | 250 | 561 | |
| NA | 2,968.77 | 45.94% | 0.66 | 67 | 782 | |
| NA | 4,111.80 | 187.68% | 0.00 | 48 | 150 | |
| BUY | 6,486.47 | 8.96% | 0.60 | 78 | 1,286 | |
| NA | 143.15 | 1.46% | 0.74 | 9 | 96 |
Search interest for Ind-Swift Laboratories Ltd Stock has increased by 47% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:47% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd’s net profit jumped 1848.78% since last year same period to ₹7.99Cr in the Q2 2025-2026. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated -8.89% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2011, Ind-Swift Laboratories Ltd has declared dividend of ₹1.00 per share on 25 May 2011 - translating a dividend yield of 2.09%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 44.92% to 45.02% in Sep 2025 quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 167.32 Cr → 170.5 Cr (in ₹), with an average increase of 1.9% per quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 13.5% return, outperforming this stock by 29.9%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.1% return, outperforming this stock by 99.5%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 39.50% of holdings in Sep 2025 quarter
Price Dip
![]()
In the last 1 month, INDSWFTLAB stock has moved down by -8.0%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 14.91% to 14.80% in Sep 2025 quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, 222.27 Cr → 7.99 Cr (in ₹), with an average decrease of 52.5% per quarter
| Organisation | Ind-Swift Laboratories Ltd |
| Headquarters | Chandigarh |
| Industry | Pharmaceuticals |
| CEO | N R Munjal |
| E-voting on shares | Click here to vote |
Ind-Swift Laboratories Ltd share price today stands at ₹91.35 as on at the close of the market. Ind-Swift Laboratories Ltd share today touched a day high of ₹96.76 and a low of ₹90.9.
Ind-Swift Laboratories Ltd touched a 52 week high of ₹124 and a 52 week low of ₹68.72. Ind-Swift Laboratories Ltd share price today i.e. is closed at ₹91.35, which is -26.33% down from its 52 week high and 32.93% up from its 52 week low.
Ind-Swift Laboratories Ltd market capitalisation is ₹782.65 Cr as on .
To buy Ind-Swift Laboratories Ltd shares, you need to follow these steps:
Ind-Swift Laboratories Ltd trading volume is 1.20L as on . This means that 1.20L shares of Ind-Swift Laboratories Ltd were bought and sold on the stock market during today's trading session.